Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clear-cell odontogenic carcinoma].

V D Ermilova1, N L Ushakova

  • 1N.N. Blokhin Cancer Research Center, 115478, Moscow.

Arkhiv Patologii
|December 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soluble forms of PD-1/PD-L immune checkpoint receptor and ligand in blood serum of breast cancer patients: association with clinical pathologic factors and molecular type of the tumor.

Klinicheskaia laboratornaia diagnostika·2022
Same author

[Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis].

Molekuliarnaia biologiia·2018
Same author

Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.

Bulletin of experimental biology and medicine·2018
Same author

Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.

Bulletin of experimental biology and medicine·2018
Same author

[Methylation of the genes for the microRNAs miR-129-2 and miR-9-1, changes in their expression, and activation of their potential target genes in clear cell renal cell carcinoma].

Molekuliarnaia biologiia·2017
Same author

Organotypic growth and differentiation of human mammary gland in sponge-gel matrix supported histoculture.

In vitro cellular & developmental biology. Animal·2016

Clear-cell odontogenic tumor, initially classified as benign, exhibits malignant behavior. Recurrences and distant metastases highlight its aggressive nature, challenging current classifications.

Area of Science:

  • Oral pathology
  • Oncology
  • Head and neck cancer

Background:

  • The classification of odontogenic tumors is crucial for accurate diagnosis and treatment planning.
  • The World Health Organization (WHO) classification system is the standard for categorizing these lesions.
  • Clear-cell odontogenic tumor (CCOT) has been historically debated regarding its biological behavior.

Observation:

  • A specific case initially diagnosed as ameloblastoma presented with characteristics requiring re-evaluation.
  • The observed tumor exhibited features that contradicted a benign diagnosis, prompting further investigation.

Findings:

  • Despite its inclusion as a benign entity in the latest WHO classification, CCOT demonstrates a propensity for aggressive behavior.
  • Literature review and case observations indicate repeated recurrences and the potential for distant metastases associated with CCOT.

Related Experiment Videos

  • This suggests that CCOT possesses malignant potential, irrespective of its current benign classification.
  • Implications:

    • The findings necessitate a re-evaluation of the current WHO classification of clear-cell odontogenic tumors.
    • Clinical management strategies for CCOT should consider its potential for malignancy, including aggressive local recurrence and distant spread.
    • Further research is warranted to elucidate the molecular mechanisms underlying CCOT's malignant behavior and to refine diagnostic criteria.